Stocks-BIIB-Biogen Inc

BIIB Biogen Inc

286.15 -2.13 (-0.74%)
Delayed Prices By NASDAQ, in USD Market Open
Invest

About Biogen Inc

Biogen, Inc. is a biopharmaceutical company founded in 1978. It specialises in designing medications targeting neurological and neurodegenerative disorders. Headquartered in Cambridge, Massachusetts, Biogen operates internationally in the Americas, Europe, Australia, and Asia. The company is listed on the NASDAQ under the ticker BIIB. Broaden your investment scope by buying BIIB stock.
9.6K
Employees
Cambridge, Massachusetts, US
HQ
1978
Founded
Christopher A. Viehbacher, CPA
CEO
Show More

Upcoming Earnings

15
FEB
REPORTS
Biogen Inc Q4 2022 earnings report is expected to be released before market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
338.00

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
54
Medium
Industry 
Avg. 45 
62
Environment
62
Social
42
Governance

People Also Bought